The investment level planned by the six largest drug makers in the plants they have in Romania reaches RON350 million in the 2024-2025 period, in line with ZF calculations, as projects are starting to shape up.
Allianz-Tiriac, the second largest insurer in Romania, ended 2023 with RON3.5 billion underwritings, up 21%, and RON346 million, 44% higher than in 2022.